Cargando…

Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis

BACKGROUND: Dry eye disease (DED) has shown a significant increase in recent years, which seriously affects people's work and life. Xiaosheng Powder, a traditional Chinese medicine decoction, has been widely used in treating DED. However, there is no systematic review of the results of the stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Chen, Shuntai, Hao, Xiaofeng, Wu, Gaiping, Wang, Shihui, Yuan, Hang, Jin, Qi, Sun, Mei, Xie, Like
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458267/
https://www.ncbi.nlm.nih.gov/pubmed/32871956
http://dx.doi.org/10.1097/MD.0000000000022019
_version_ 1783576161103642624
author Xu, Jing
Chen, Shuntai
Hao, Xiaofeng
Wu, Gaiping
Wang, Shihui
Yuan, Hang
Jin, Qi
Sun, Mei
Xie, Like
author_facet Xu, Jing
Chen, Shuntai
Hao, Xiaofeng
Wu, Gaiping
Wang, Shihui
Yuan, Hang
Jin, Qi
Sun, Mei
Xie, Like
author_sort Xu, Jing
collection PubMed
description BACKGROUND: Dry eye disease (DED) has shown a significant increase in recent years, which seriously affects people's work and life. Xiaosheng Powder, a traditional Chinese medicine decoction, has been widely used in treating DED. However, there is no systematic review of the results of the study on this therapeutic effect. The purpose of this review is to evaluate the effectiveness and safety of Xiaosheng Powder in the treatment of DED. METHODS AND ANALYSIS: The electronic databases to be searched will include MEDLINE (PubMed), Cochrane Central Register of Controlled Trials in the Cochrane Library, Excerpta Medica Database, China National Knowledge Infrastructure, China Scientific Journal Database, Wanfang Database and Chinese Biomedical Literature Database. Papers in English or Chinese published from inception to 2020 will be included without any restrictions. Improvement in Ocular Surface Disease Index will be assessed as the primary outcomes. Tear break-up time, Schirmer I test, fluorescent, adverse events, and the recurrence rate after at least 3 months of the treatment will be evaluated as secondary outcomes. We will conduct a meta-analysis of randomized controlled trial if possible. The methodological qualities, including the risk of bias, will be evaluated using the Cochrane risk of bias assessment tool, while confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development, and Evaluation approach. ETHICS AND DISSEMINATION: It is not necessary for a formal ethical approval because the data is not individualized. The results of this review will offer implications for the use of Xiaosheng Powder as a treatment for DED. This knowledge will inform recommendations by ophthalmologist and researchers who are interested in the treatment of DED. The findings of this systematic review will be disseminated through peer-reviewed publications and conference presentations. TRAIL REGISTRATION NUMBER: PROSPERO CRD42020147709.
format Online
Article
Text
id pubmed-7458267
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74582672020-09-16 Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis Xu, Jing Chen, Shuntai Hao, Xiaofeng Wu, Gaiping Wang, Shihui Yuan, Hang Jin, Qi Sun, Mei Xie, Like Medicine (Baltimore) 3800 BACKGROUND: Dry eye disease (DED) has shown a significant increase in recent years, which seriously affects people's work and life. Xiaosheng Powder, a traditional Chinese medicine decoction, has been widely used in treating DED. However, there is no systematic review of the results of the study on this therapeutic effect. The purpose of this review is to evaluate the effectiveness and safety of Xiaosheng Powder in the treatment of DED. METHODS AND ANALYSIS: The electronic databases to be searched will include MEDLINE (PubMed), Cochrane Central Register of Controlled Trials in the Cochrane Library, Excerpta Medica Database, China National Knowledge Infrastructure, China Scientific Journal Database, Wanfang Database and Chinese Biomedical Literature Database. Papers in English or Chinese published from inception to 2020 will be included without any restrictions. Improvement in Ocular Surface Disease Index will be assessed as the primary outcomes. Tear break-up time, Schirmer I test, fluorescent, adverse events, and the recurrence rate after at least 3 months of the treatment will be evaluated as secondary outcomes. We will conduct a meta-analysis of randomized controlled trial if possible. The methodological qualities, including the risk of bias, will be evaluated using the Cochrane risk of bias assessment tool, while confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development, and Evaluation approach. ETHICS AND DISSEMINATION: It is not necessary for a formal ethical approval because the data is not individualized. The results of this review will offer implications for the use of Xiaosheng Powder as a treatment for DED. This knowledge will inform recommendations by ophthalmologist and researchers who are interested in the treatment of DED. The findings of this systematic review will be disseminated through peer-reviewed publications and conference presentations. TRAIL REGISTRATION NUMBER: PROSPERO CRD42020147709. Lippincott Williams & Wilkins 2020-08-28 /pmc/articles/PMC7458267/ /pubmed/32871956 http://dx.doi.org/10.1097/MD.0000000000022019 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Xu, Jing
Chen, Shuntai
Hao, Xiaofeng
Wu, Gaiping
Wang, Shihui
Yuan, Hang
Jin, Qi
Sun, Mei
Xie, Like
Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis
title Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis
title_full Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis
title_fullStr Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis
title_full_unstemmed Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis
title_short Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis
title_sort traditional chinese medicine xiaosheng powder for dry eye disease: a protocol for systematic review and meta analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458267/
https://www.ncbi.nlm.nih.gov/pubmed/32871956
http://dx.doi.org/10.1097/MD.0000000000022019
work_keys_str_mv AT xujing traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT chenshuntai traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT haoxiaofeng traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT wugaiping traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT wangshihui traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT yuanhang traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT jinqi traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT sunmei traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis
AT xielike traditionalchinesemedicinexiaoshengpowderfordryeyediseaseaprotocolforsystematicreviewandmetaanalysis